Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Major Depressive Disorder | Treatment Algorithms | Claims Data Analysis | US | 2015
For the treatment of major depressive disorder (MDD), which affects more than 17 million people in the United States, there are multiple prescription therapies that are used to treat depressive…
Chronic Kidney Disease (Market Access Challenges Facing Chronic Kidney Disease Treatments) | Physician & Payer Forum | China | 2015
Physician Perspectives and the Impact of Payer Policy on Prescribing An estimated 121 million people are living with chronic kidney disease (CKD) in China. This high prevalence can be…
How Will U.S. Physicians and Payers Respond to Additional LABA/LAMA FDCs in the Increasingly Crowded COPD Market? | Physician & Payer Forum | US | 2015
A Survey of Pulmonologists and Managed Care Organization Pharmacy and Medical Directors The U.S. market for chronic obstructive pulmonary disease (COPD) therapies consists entirely of…
Chronic Kidney Disease (Market Access Challenges Facing Chronic Kidney Disease Treatments) | Physician & Payer Forum | Brazil/Mexico | 2015
A Survey of Medical Nephrologists and Interviews with Payers Chronic kidney disease (CKD) and its underlying conditions (diabetes and hypertension) are among the top causes of disability-…
The Evolving Market Access Landscape for Spondyloarthritis | Physician & Payer Forum | EU5 | 2015
Physician and Payer Perspectives on Biologic Use and Novel Therapeutic Targets in the Treatment of Psoriatic Arthritis, Ankylosing Spondylitis, and Nonradiographic Axial Spondyloarthritis…
